PlainRecalls
FDA Drug Moderate Class II Ongoing

Cinacalcet Hydrochloride Tablets, 30 mg, 30 Tablets per bottle, Rx Only, Manufactured for: Cipla USA, Inc., 10 Independence Boulevard, Suite 300, Warren, NJ 07059. NDC: 69097-410-02

Reported: December 17, 2025 Initiated: November 14, 2025 #D-0224-2026

Product Description

Cinacalcet Hydrochloride Tablets, 30 mg, 30 Tablets per bottle, Rx Only, Manufactured for: Cipla USA, Inc., 10 Independence Boulevard, Suite 300, Warren, NJ 07059. NDC: 69097-410-02

Reason for Recall

CGMP Deviations: the presence of a nitrosamine impurity, N-nitroso-cinacalcet, above the acceptable daily intake (ADI) limits.

Details

Recalling Firm
Cipla USA, Inc.
Units Affected
63,504 bottles
Distribution
Nationwide in the US
Location
Warren, NJ

Frequently Asked Questions

What product was recalled?
Cinacalcet Hydrochloride Tablets, 30 mg, 30 Tablets per bottle, Rx Only, Manufactured for: Cipla USA, Inc., 10 Independence Boulevard, Suite 300, Warren, NJ 07059. NDC: 69097-410-02. Recalled by Cipla USA, Inc.. Units affected: 63,504 bottles.
Why was this product recalled?
CGMP Deviations: the presence of a nitrosamine impurity, N-nitroso-cinacalcet, above the acceptable daily intake (ADI) limits.
Which agency issued this recall?
This recall was issued by the FDA Drug on December 17, 2025. Severity: Moderate. Recall number: D-0224-2026.